Form 4: Leidos Holdings Director Kovarik Exercises Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Director Robert C. Kovarik Jr. exercised stock options and sold shares of Leidos Holdings, Inc. on February 13, 2025.

Summary

  • On February 13, 2025, Robert C. Kovarik Jr., a director of Leidos Holdings, Inc., exercised stock options to acquire 3,345 shares of common stock at a price of $75.02 per share.
  • Following the exercise, Kovarik disposed of shares to cover the exercise price and associated fees, with 1,834 shares withheld by the issuer.
  • Additionally, Kovarik sold 1,511 shares in the open market at a weighted average price of $134.5613, with individual sales ranging from $134.51 to $134.665.
  • After these transactions, Kovarik directly owns 6,408 shares of Leidos Holdings, Inc.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies like Leidos. These transactions are closely watched by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • Insider transactions are a normal part of corporate governance and are regularly disclosed by executives and directors at companies like Lockheed Martin (LMT), General Dynamics (GD), and Northrop Grumman (NOC).
  • The scale of these transactions is typical for director-level compensation and portfolio management.
  • The reporting requirements are standardized across all publicly traded companies in the US.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely negligible given the relatively small number of shares involved.
  • Employees are unlikely to be directly affected by this transaction.

Key Dates

DateDescription
05/01/2020Date stock options were exercisable
05/09/2026Expiration date of stock options
02/13/2025Date of stock option exercise and share sales
02/14/2025Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.